Guidance for industry in the manufacture and clinical evaluation of in vitro tests to detect nucleic acid sequences of human immunodeficiency viruses types 1 and 2.

Other author Center for Biologics Evaluation and Research (U.S.)
Format Electronic
Publication InfoRockville, MD : U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research, [1999]
Descriptioni, 22 p. : digital, PDF file
Supplemental Contenthttps://purl.fdlp.gov/GPO/LPS113528
Subjects

Portion of title Manufacture and clinical evaluation of in vitro tests to detect nucleic acid sequences of human immunodeficiency viruses types 1 and 2
General noteTitle from PDF title page (viewed on June 5, 2009).
General note"December 1999".
General noteGPO Cataloging Record Distribution Program (CRDP).
Bibliography noteIncludes bibliographical references (p. 20).
Technical detailsMode of access: Internet at the FDA web site. Address as of 6/5/09: http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Blood/ucm080790.pdf ; current access is available via PURL.
GPO item number0499-T-02 (online)
Govt. docs number HE 20.4802:M 31/2

Availability

Library Location Call Number Status Item Actions
Electronic Resources Access Content Online ✔ Available